Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)
Today: 27/07/2026 · PREPARE NOW · Open · Viewed
Funding agency: Horizon Europe
Call: HORIZON-EURATOM-LS-2026-01
Type of action: HORIZON-IA HORIZON Innovation Actions | Deadline model: single-stage | Planned opening: 23/04/2026 | Model Grant Agreement: HORIZON Lump Sum Grant
The call aims to promote nuclear research and training in Europe. It supports the development of stable isotopes for novel nuclear medicine therapies.
Budget total: 2000000.0 EUR | Budget per project: — EUR
Deadline: 15/09/2026 (50 days left) | Duration: — months | Funding intensity: —% | Type: innovation
Eligibility: entity types: university, research institute; countries: EU countries
#nuclear medicine#stable isotopes#research#training
HealthResearch & Development Digital solutionsMaterials
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| Novatex Solutions LTD | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'SME' not among eligible en…Excluded by eligibility/preference filters: Org type 'SME' not among eligible entity types ['university', 'research institute']. |
Override |
| European Centre for Emerging Competencies and Technologies | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'non-profit' not among elig…Excluded by eligibility/preference filters: Org type 'non-profit' not among eligible entity types ['university', 'research institute']. |
Override |